Literature DB >> 33172846

Have large increases in fast track referrals improved bowel cancer outcomes in UK?

Michael Thompson1, Daniel O'Leary2, Iona Heath3, Lynn Faulds Wood3, Brian Ellis2, Karen Flashman2, Neil Smart4, John Nicholls5, Neil Mortensen6, Paul Finan7, Asha Senapati2, Robert Steele8, Peter Dawson5, James Hill9, Brendan Moran10.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33172846     DOI： 10.1136/bmj.m3273

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Urinary Volatile Organic Compound Testing in Fast-Track Patients with Suspected Colorectal Cancer.

Authors:  Caroline E Boulind; Oliver Gould; Ben de Lacy Costello; Joanna Allison; Paul White; Paul Ewings; Alfian N Wicaksono; Nathan J Curtis; Anne Pullyblank; David Jayne; James A Covington; Norman Ratcliffe; Claire Turner; Nader K Francis
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

2.  Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy.

Authors:  C C Kearsey; C Graham; H S Lobb; J Chacko; R Weatherburn; P S Rooney
Journal:  BMC Fam Pract       Date:  2021-05-12       Impact factor: 2.497

3.  Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study.

Authors:  Andrea K Roalfe; Sarah L Lay-Flurrie; José M Ordóñez-Mena; Clare R Goyder; Nicholas R Jones; F D Richard Hobbs; Clare J Taylor
Journal:  Eur Heart J       Date:  2021-11-30       Impact factor: 35.855

4.  Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care.

Authors:  Diana R Withrow; Brian Shine; Jason Oke; Andres Tamm; Tim James; Eva Morris; Jim Davies; Steve Harris; James E East; Brian D Nicholson
Journal:  BMC Med       Date:  2022-03-15       Impact factor: 8.775

5.  An internal pilot study of a novel rectal mucocellular sampling device to allow next-generation sequencing for colorectal disease.

Authors:  H N Humphrey; A Diodato; J-C Isner; E Walker; J Lacy-Colson; B Nedjai; I R Daniels
Journal:  Tech Coloproctol       Date:  2022-09-27       Impact factor: 3.699
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.